advertisement
Miraftabi A 10
Showing records 1 to 10 | Display all abstracts from Miraftabi A100718 Trans-Scleral Cyclophotocoagulation in Refractory Pigment Dispersion-Like Glaucoma Secondary to Ciliary Body Melanoma
Banifatemi M
Journal of current ophthalmology 2022; 34: 118-120
99413 Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab
Nilforushan N; Es'haghi A
British Journal of Ophthalmology 2022; 106: 648-654
100718 Trans-Scleral Cyclophotocoagulation in Refractory Pigment Dispersion-Like Glaucoma Secondary to Ciliary Body Melanoma
Nilforushan N
Journal of current ophthalmology 2022; 34: 118-120
99413 Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab
Miraftabi A
British Journal of Ophthalmology 2022; 106: 648-654
100718 Trans-Scleral Cyclophotocoagulation in Refractory Pigment Dispersion-Like Glaucoma Secondary to Ciliary Body Melanoma
Sedaghat A
Journal of current ophthalmology 2022; 34: 118-120
99413 Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab
Abolfathzadeh N
British Journal of Ophthalmology 2022; 106: 648-654
100718 Trans-Scleral Cyclophotocoagulation in Refractory Pigment Dispersion-Like Glaucoma Secondary to Ciliary Body Melanoma
Miraftabi A
Journal of current ophthalmology 2022; 34: 118-120
99413 Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab
Abolfathzadeh N
British Journal of Ophthalmology 2022; 106: 648-654
100718 Trans-Scleral Cyclophotocoagulation in Refractory Pigment Dispersion-Like Glaucoma Secondary to Ciliary Body Melanoma
Abolfathzadeh N; Abolfathzadeh N
Journal of current ophthalmology 2022; 34: 118-120
99413 Trabeculectomy in patients with diabetes: subconjunctival Mitomycin C with or without intravitreal bevacizumab
Banifatemi M
British Journal of Ophthalmology 2022; 106: 648-654
